29 May, 2010
The trial Saudi FDA recall of Avandia is questioned while Avandia lawsuit settlements are reached in the U.S..
Despite growing evidence of the cardiovascular risks associated with Avandia, a leading Saudi diabetes doctor would like to its FDA recall reversed. Meanwhile, the first round Avandia lawsuit settlements have been reported in the U.S.. Continue reading Saudi FDA recall of Avandia is questioned while Avandia lawsuit settlements are reached in U.S.Category: Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements
20 May, 2010
GSK is having serious problems recruiting volunteers to participate in a large clinical trial of Avandia.
Two sites in the U.S. recently have withdrawn from the study due to poor enrollment. Several previous studies have linked the diabetes drug to an increased risk of heart attack. In response, Glaxo opened dozens of new Avandia trial sites last month outside the U.S. in developing nations, where participants may not be aware of the safety questions surrounding the diabetes drug. Continue reading Avandia trial: Glaxo having problems recruiting patient volunteersCategory: Avandia Cardiovascular Risk | Avandia News | Avandia Safety
16 May, 2010
GlaxoSmithKline may pay more than $1 billion to settle Avandia lawsuits.
The defective drug litigation has reached the point where more Avandia settlements are expected in the near future. Continue reading Avandia settlements may exceed $1 billion
12 May, 2010
Avandia lawsuit settlements have been reached in hundreds of cases. Glaxo will pay millions but the exact settlement amounts are being kept confidential.
Glaxo has settled nearly 700 of the lawsuits filed by people harmed by Avandia. Most of the settled cases are for people who had heart attacks after taking the diabetes drug. Other injuries include stroke and congestive heart failure. Many are wrongful death claims. Continue reading Settlements reached in hundreds of Avandia lawsuits, settlement amounts confidentialCategory: Avandia Recall | Avandia Settlements
8 May, 2010
Glaxo will defend Avandia at a July FDA meeting from calls for a recall. The drug company faces over 2,000 Avandia lawsuits filed after a 2007 study linked heart attack and congestive heart failure to Avandia use. Continue reading Avandia drugmaker will continue to defend drug from lawsuits and recall, says Glaxo CEOCategory: Avandia News | Avandia Recall
2 May, 2010
In testimony to Congress, consumer group demands Avandia recall and halt to the TIDE drug safety trial
Dr. Sidney Wolfe, Director of the Health Research Group at the non-profit consumer advocacy group Public Citizen, testified that the health and safety of thousands of innocent people are being jeopardized by allowing the TIDE trial to continue. Continue reading Leading drug safety expert to Congress: Recall Avandia and stop TIDE trialCategory: Avandia FDA | Avandia News | Avandia Recall | Avandia Safety